Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę "Merkelbach, Matthias" wg kryterium: Autor


Wyświetlanie 1-86 z 86
Tytuł :
Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrence
Autorzy :
Gassa, Asmae
Pokaż więcej
Źródło :
In Lung Cancer January 2021 151:91-96
Czasopismo naukowe
Tytuł :
ALK G1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor
Autorzy :
Sebastian Y. F. Michels
Andreas H. Scheel
Thomas Wündisch
Johannes M. Heuckmann
Roopika Menon
Michael Puesken
Carsten Kobe
Helen Pasternack
Carina Heydt
Matthias Scheffler
Rieke Fischer
Anne M. Schultheis
Sabine Merkelbach-Bruse
Lukas Heukamp
Reinhard Büttner
Jürgen Wolf
Pokaż więcej
Temat :
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło :
npj Precision Oncology, Vol 1, Iss 1, Pp 1-4 (2017)
Opis pliku :
electronic resource
Relacje :
https://doaj.org/toc/2397-768X
Dostęp URL :
https://doaj.org/article/33a80232e38044a3a05d9a9bbd74b52a
Czasopismo naukowe
Tytuł :
Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma
Autorzy :
Quaas, Alexander
Heydt, Carina
Waldschmidt, Dirk
Alakus, Hakan
Zander, Thomas
Goeser, Tobias
Kasper, Philipp
Bruns, Christiane
Brunn, Anna
Roth, Wilfried
Hartmann, Nils
Bunck, Anne
Schmidt, Matthias
Buettner, Reinhard
Merkelbach-Bruse, Sabine
Pokaż więcej
Źródło :
BMC Gastroenterology. 19(1)
Czasopismo naukowe
Tytuł :
ALK mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor
Autorzy :
Michels, Sebastian Y. F.Aff1, Aff2
Scheel, Andreas H.Aff1, Aff3
Wündisch, Thomas
Heuckmann, Johannes M.
Menon, Roopika
Puesken, Michael
Kobe, Carsten
Pasternack, HelenAff1, Aff3
Heydt, CarinaAff1, Aff3
Scheffler, MatthiasAff1, Aff2
Fischer, RiekeAff1, Aff2
Schultheis, Anne M.Aff1, Aff3
Merkelbach-Bruse, SabineAff1, Aff3
Heukamp, LukasAff5, Aff8
Büttner, ReinhardAff1, Aff3
Wolf, JürgenAff1, Aff2
Pokaż więcej
Źródło :
npj Precision Oncology. 1(1)
Czasopismo naukowe
Tytuł :
Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient
Autorzy :
Scheffler, Matthias
Merkelbach-Bruse, Sabine
Bos, Marc
Fassunke, Jana
Gardizi, Masyar
Michels, Sebastian
Groneck, Laura
Schultheis, Anne M
Malchers, Florian
Leenders, Frauke
Kobe, Carsten
König, Katharina
Heukamp, Lukas C.
Sos, Martin L.
Thomas, Roman K.
Büttner, Reinhard
Wolf, Jürgen
Pokaż więcej
Temat :
Oncology
Pulmonary and Respiratory Medicine
Źródło :
Journal of Thoracic Oncology. 10
Tytuł :
Effects of altered phosphoenolpyruvate carboxylase activities on transgenic C3 plant Solanum tuberosum
Autorzy :
Gehlen, Johanna
Panstruga, Ralph
Smets, Helga
Merkelbach, Sabine
Kleines, Michael
Porsch, Petra
Fladung, Matthias
Becker, Irmgard
Rademacher, Thomas
Häusler, Rainer E.
Hirsch, Heinz-Josef
Pokaż więcej
Źródło :
Plant Molecular Biology: An International Journal on Molecular Biology, Molecular Genetics and Biochemistry. December 1996 32(5):831-848
Czasopismo naukowe
Tytuł :
A Genomics-Based Classification of Human Lung Tumors
Autorzy :
Damiani, Stefania
Solomon, Benjamin
Lang, Ulrich
Muscarella, Lucia A.
Ansen, Sascha
Getz, Gad
Muley, Thomas
Kappes, Rainer
Smit, Egbert
Altmueller, Janine
Travis, William D.
Chen, Yuan
Schneider, Peter
Solberg, Steinar
Schnabel, Philipp A.
Thomas, Roman K.
Merkelbach-bruse, Sabine
Hayes, D. Neil
Brambilla, Christian
Boessmann, Ingelore
Schmitz, Stephan
Albus, Kerstin
Rogers, Toni-maree
Bogus, Magdalena
Mueller, Christian
Fricke, Rainer
Soria, Jean-charles
Ligorio, Claudia
Dahmen, Ilona
Koenig, Katharina
Groen, Harry
Brambilla, Elisabeth
Scheffler, Matthias
Krueger, Stefan
Soltermann, Alex
Bos, Marc
Peifer, Martin
Reiser, Marcel
Stoelben, Erich
Validire, Pierre
Weder, Walter
Gerigk, Ulrich
Huenerlituerkoglu, Ali-nuri
Schmitz, Katja
Clement, Joachim H.
Wolf, Juergen
Saenger, Joerg
Thunnissen, Erik
Achter, Viktor
Snijders, Peter J. F.
Cappuzzo, Federico
Moro-sibilot, Denis
Leenders, Frauke
Fazio, Vito M.
Toepelt, Karin
Nguyen, Chau
Lorimier, Philippe
Fassunke, Jana
Nuemberg, Peter
Mattonet, Christian
Carter, Scott L.
Besse, Benjamin
Ludwig, Corinna
Goekkurt, Eray
Querings, Silvia
Wilkerson, Matthew D.
Serke, Monika
Nogova, Lucia
Thomas, Roman
Binot, Elke
Wright, Gavin
Gardizi, Masyar
Heldwein, Matthias
Pao, William
Gabler, Franziska
Lund-iversen, Marius
Zander, Thomas
Fernandez-cuesta, Lynnette
Kambartel, Kato
Engel-riedel, Walburga
Ko, Yon-dschun
Hallek, Michael
Meffert, Lisa
Kuenstlinger, Helen
Buettner, Reinhard
Heideman, Danille A. M.
Sietsma, Hannie
Behringer, Dirk
Hoffmann, Hans
Russell, Prudence
Randerath, Winfried
Kleine, Michaela
Hekmat, Khosro
Galetke, Wolfgang
Helland, Aslaug
Heukamp, Lukas C.
Schlesinger, Andreas
Lantuejoul, Sylvie
Seidel, Danila
Girard, Philippe
Wilkening, Ines
Schildhaus, Hans-ulrich
Lu, Xin
Perner, Sven
Hyde, Russell
Timens, Wim
Schnell, Roland
Litt-lampe, Markus
Schulte, Wolfgang
Berg, Johannes
Wainer, Zoe
Field, John K.
Frank, Konrad F.
Moch, Holger
Sos, Martin L.
Brustugun, Odd Terje
Menon, Roopika
Pokaż więcej
Źródło :
Science Translational Medicine; Vol 5
Tytuł :
Online Life Cycle Assessment for Fluid Power Manufacturing Systems – Challenges and Opportunities
Autorzy :
Rückert, Marcel
Merkelbach, Stephan
Alt, Raphael
Schmitz, Katharina
Pokaż więcej
Źródło :
Advances in Production Management Systems. Smart Manufacturing for Industry 4.0 : IFIP WG 5.7 International Conference, APMS 2018, Seoul, Korea, August 26-30, 2018, Proceedings, Part II. 536:128-135
Książka elektroniczna
Tytuł :
Crystalline phase-change materials : disorder, medium-range order and electrical switching
Autorzy :
Merkelbach, Philipp Johannes
Pokaż więcej
Temat :
neutron scattering
Phase-Change-Technologie
Strukturaufklärung
Anderson-Lokalisation
Speicher
Physik
sense organs
ddc:530
Neutronenbeugung
Anderson localisation
phase-change-technology
Źródło :
Aachen : Publikationsserver der RWTH Aachen University Getr. Zählung : Ill., graph. Darst. (2011). = Aachen, Techn. Hochsch., Diss., 2011
Tytuł :
Monitoring Treatment Response to Erlotinib in EGFR-mutated Non-small-cell Lung Cancer Brain Metastases Using Serial O-(2-[ F]fluoroethyl)-L-tyrosine PET.
Autorzy :
Abdulla DSY; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
Scheffler M; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
Brandes V; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
Ruge M; Center for Integrated Oncology Köln, Bonn, Germany; Department of Stereotaxy and Functional Neurosurgery, University Hospital of Cologne, Cologne, Germany.
Kunze S; Center for Integrated Oncology Köln, Bonn, Germany; Department of Radiotherapy, University Hospital of Cologne, Cologne, Germany.
Merkelbach-Bruse S; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany; Department of Pathology, University Hospital of Cologne, Cologne, Germany.
Nogova L; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
Michels S; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
Fischer R; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
Riedel R; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany.
Büttner R; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany; Department of Pathology, University Hospital of Cologne, Cologne, Germany.
Persigehl T; Center for Integrated Oncology Köln, Bonn, Germany; Department of Radiology, University Hospital of Cologne, Cologne, Germany.
Grau S; Center for Integrated Oncology Köln, Bonn, Germany; Department of Neurosurgery, University Hospital of Cologne, Cologne, Germany.
Galldiks N; Center for Integrated Oncology Köln, Bonn, Germany; Department of Neurology, University Hospital of Cologne, Cologne, Germany; Institute of Neuroscience and Medicine, Research Center Juelich, Juelich, Germany.
Drzezga A; Center for Integrated Oncology Köln, Bonn, Germany; Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.
Kobe C; Center for Integrated Oncology Köln, Bonn, Germany; Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.
Wolf J; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Köln, Bonn, Germany; Network Genomic Medicine (NGM) Lung Cancer, Cologne, Germany. Electronic address: .
Pokaż więcej
Źródło :
Clinical lung cancer [Clin Lung Cancer] 2019 Mar; Vol. 20 (2), pp. e148-e151. Date of Electronic Publication: 2018 Nov 05.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Brain Neoplasms/*diagnosis
Carcinoma, Non-Small-Cell Lung/*diagnosis
Erlotinib Hydrochloride/*therapeutic use
Lung Neoplasms/*diagnosis
Tyrosine/*analogs & derivatives
Adult ; Brain Neoplasms/drug therapy ; Brain Neoplasms/secondary ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/secondary ; ErbB Receptors/genetics ; Female ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Mutation/genetics ; Positron-Emission Tomography
Czasopismo naukowe
Tytuł :
Overcoming EGFR -mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors.
Autorzy :
Fassunke J; Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Müller F; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Weyertal 115b, 50931, Cologne, Germany.
Keul M; Faculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn-Str. 4a, 44227, Dortmund, Germany.
Michels S; Lung Cancer Group Cologne and Network Genomic Medicine (Lung Cancer), Department I of Internal Medicine, Center for Integrated Oncology Cologne-Bonn, University Hospital Cologne, Kerpener Str. 62, 50931, Cologne, Germany.
Dammert MA; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Weyertal 115b, 50931, Cologne, Germany.
Schmitt A; Center for Molecular Medicine Cologne, University of Cologne, Robert-Koch-Str. 21, 50931, Cologne, Germany.; Department I of Internal Medicine, University Hospital of Cologne, Weyertal 115b, 50931, Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Joseph Stelzmann Str. 26, 50931, Cologne, Germany.
Plenker D; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Weyertal 115b, 50931, Cologne, Germany.
Lategahn J; Faculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn-Str. 4a, 44227, Dortmund, Germany.
Heydt C; Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Brägelmann J; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Weyertal 115b, 50931, Cologne, Germany.
Tumbrink HL; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Weyertal 115b, 50931, Cologne, Germany.
Alber Y; Faculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn-Str. 4a, 44227, Dortmund, Germany.
Klein S; Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Weyertal 115b, 50931, Cologne, Germany.; Else Kröner Forschungskolleg Clonal Evolution in Cancer, University Hospital Cologne, Weyertal 115b, 50931, Cologne, Germany.
Heimsoeth A; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Weyertal 115b, 50931, Cologne, Germany.
Dahmen I; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Weyertal 115b, 50931, Cologne, Germany.
Fischer RN; Lung Cancer Group Cologne and Network Genomic Medicine (Lung Cancer), Department I of Internal Medicine, Center for Integrated Oncology Cologne-Bonn, University Hospital Cologne, Kerpener Str. 62, 50931, Cologne, Germany.
Scheffler M; Lung Cancer Group Cologne and Network Genomic Medicine (Lung Cancer), Department I of Internal Medicine, Center for Integrated Oncology Cologne-Bonn, University Hospital Cologne, Kerpener Str. 62, 50931, Cologne, Germany.
Ihle MA; Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Priesner V; Lung Cancer Group Cologne and Network Genomic Medicine (Lung Cancer), Department I of Internal Medicine, Center for Integrated Oncology Cologne-Bonn, University Hospital Cologne, Kerpener Str. 62, 50931, Cologne, Germany.
Scheel AH; Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Wagener S; Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Kron A; Lung Cancer Group Cologne and Network Genomic Medicine (Lung Cancer), Department I of Internal Medicine, Center for Integrated Oncology Cologne-Bonn, University Hospital Cologne, Kerpener Str. 62, 50931, Cologne, Germany.
Frank K; Section Pneumology, Clinic III of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Garbert K; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Weyertal 115b, 50931, Cologne, Germany.
Persigehl T; Institute of Diagnostic and Interventional Radiology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Püsken M; Institute of Diagnostic and Interventional Radiology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Haneder S; Institute of Diagnostic and Interventional Radiology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Schaaf B; Hospital Dortmund gGmbH, Muensterstrasse 240, 44145, Dortmund, Germany.
Rodermann E; Onkologie Rhein-Sieg, Schloßstraße 18, 53840, Troisdorf, Germany.
Engel-Riedel W; Department of Pneumology, Lung Hospital Cologne Merheim, City of Cologne Municipal Hospitals, Cologne, Germany.
Felip E; Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Smit EF; Thoracic Oncology Service, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Merkelbach-Bruse S; Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Reinhardt HC; Center for Molecular Medicine Cologne, University of Cologne, Robert-Koch-Str. 21, 50931, Cologne, Germany.; Department I of Internal Medicine, University Hospital of Cologne, Weyertal 115b, 50931, Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Joseph Stelzmann Str. 26, 50931, Cologne, Germany.
Kast SM; Faculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn-Str. 4a, 44227, Dortmund, Germany.
Wolf J; Lung Cancer Group Cologne and Network Genomic Medicine (Lung Cancer), Department I of Internal Medicine, Center for Integrated Oncology Cologne-Bonn, University Hospital Cologne, Kerpener Str. 62, 50931, Cologne, Germany. .
Rauh D; Faculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn-Str. 4a, 44227, Dortmund, Germany. .
Büttner R; Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. .; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Weyertal 115b, 50931, Cologne, Germany. .; Lung Cancer Group Cologne and Network Genomic Medicine (Lung Cancer), Department I of Internal Medicine, Center for Integrated Oncology Cologne-Bonn, University Hospital Cologne, Kerpener Str. 62, 50931, Cologne, Germany. .
Sos ML; Molecular Pathology, Institute of Pathology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. .; Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Weyertal 115b, 50931, Cologne, Germany. .; Center for Molecular Medicine Cologne, University of Cologne, Robert-Koch-Str. 21, 50931, Cologne, Germany. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2018 Nov 07; Vol. 9 (1), pp. 4655. Date of Electronic Publication: 2018 Nov 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Neoplasm/*drug effects
ErbB Receptors/*antagonists & inhibitors
Piperazines/*pharmacology
Protein Kinase Inhibitors/*pharmacology
Acrylamides ; Aniline Compounds ; Animals ; Cell Line, Tumor ; Disease Progression ; ErbB Receptors/chemistry ; ErbB Receptors/metabolism ; Female ; Humans ; Kinetics ; Mice ; Mice, Nude ; Mutation/genetics ; NIH 3T3 Cells ; Piperazines/chemistry ; Protein Binding/drug effects ; Protein Conformation ; Protein Kinase Inhibitors/chemistry
Czasopismo naukowe
Tytuł :
Clinical and Pathological Characteristics of KEAP1 - and NFE2L2 -Mutated Non-Small Cell Lung Carcinoma (NSCLC).
Autorzy :
Frank R; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Scheffler M; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Merkelbach-Bruse S; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Ihle MA; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Kron A; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Rauer M; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD) Research Center and Systems Biology of Ageing Cologne, University of Cologne, Cologne, Germany.
Ueckeroth F; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
König K; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Michels S; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Fischer R; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Eisert A; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Fassunke J; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Heydt C; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Serke M; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Department for Pulmonology and Thoracic Oncology, Lung Clinic Hemer, Hemer, Germany.
Ko YD; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Johanniter Hospital, Evangelical Clinics of Bonn, Bonn, Germany.
Gerigk U; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Marien-Hospital Bonn, GFO Clinics Bonn, Bonn, Germany.
Geist T; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Center Practice for Lung and Bronchial Diseases, Düsseldorf, Germany.
Kaminsky B; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Clinic for Pulmonology and Allergology, Bethanien Hospital Solingen, Solingen, Germany.
Heukamp LC; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Clement-Ziza M; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD) Research Center and Systems Biology of Ageing Cologne, University of Cologne, Cologne, Germany.
Büttner R; Network Genomic Medicine (Lung Cancer), Cologne, Germany.; Institute of Pathology, University Hospital of Cologne, Cologne, Germany.
Wolf J; Lung Cancer Group Cologne, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. .; Network Genomic Medicine (Lung Cancer), Cologne, Germany.
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Jul 01; Vol. 24 (13), pp. 3087-3096. Date of Electronic Publication: 2018 Apr 03.
Typ publikacji :
Journal Article
MeSH Terms :
Mutation*
Carcinoma, Non-Small-Cell Lung/*genetics
Carcinoma, Non-Small-Cell Lung/*pathology
Kelch-Like ECH-Associated Protein 1/*genetics
Lung Neoplasms/*genetics
Lung Neoplasms/*pathology
NF-E2-Related Factor 2/*genetics
Antineoplastic Agents/therapeutic use ; Biomarkers, Tumor ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/mortality ; Cell Line, Tumor ; Female ; Genetic Association Studies ; Genetic Predisposition to Disease ; High-Throughput Nucleotide Sequencing ; Humans ; Immunohistochemistry ; In Situ Hybridization, Fluorescence ; Kelch-Like ECH-Associated Protein 1/metabolism ; Lung Neoplasms/drug therapy ; Lung Neoplasms/mortality ; Male ; NF-E2-Related Factor 2/metabolism ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe
    Wyświetlanie 1-86 z 86

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies